Pharmacokinetics of Ro 23-6240 (AM 833) , a new trifluorinated quinolone
Weidekamm, E.; Stöckel, K.; Dell, D.
Chemioterapia International Journal of the Mediterranean Society of ChemoTherapy 6(2 Suppl): 307-308
1987
ISSN/ISBN: 0392-906X PMID: 3151346 Document Number: 301352
Document emailed within 1 workday
Related Documents
Budanov, S.V.; Smirnova, L.B. 2001: Levofloxacin (Tavanic)--a novel quinolone of the IIi generation. Antimicrobial activity, pharmacokinetics, clinical significance Antibiotiki i Khimioterapiia 46(5): 31-38Saga, T. 2012: New mechanisms of quinolone resistance among Enterobacteriaceae: focused on plasmid-mediated quinolone resistance Nihon Rinsho. Japanese Journal of Clinical Medicine 70(2): 333-338
Vincent, S.; Machado, L.; Cooper, T.W.; Bronze, M.S.; Greenfield, R.A. 2007: Part IX. Quinolone antimicrobials Journal of the Oklahoma State Medical Association 100(5): 149-156
Kostić, D. 1996: Fleroxacin--a new quinolone antibiotic Vojnosanitetski Pregled 53(4): 311-324
King, D.E.; Malone, R.; Lilley, S.H. 2000: New classification and update on the quinolone antibiotics American Family Physician 61(9): 2741-2748
Brion, N.; Contrepois, A.; Carbon, C. 1983: From serum pharmacokinetics to extravascular pharmacokinetics of antibiotics. Importance of protein binding Presse Medicale 12(5): 293-296
Paxton, J.W. 1981: Elementary pharmacokinetics in clinical practice 4: genetic, environmental and age influences on pharmacokinetics New Zealand Medical Journal 94(697): 423-425
Felmingham, D.; O'Hare, M.D.; Robbins, M.J.; Wall, R.A.; Williams, A.H.; Cremer, A.W.; Ridgway, G.L.; Grüneberg, R.N. 1985: Comparative in vitro studies with 4-quinolone antimicrobials Drugs under Experimental and Clinical Research 11(5): 317-329
Tang, Y.; Wu, K.; Feng, X.; Huang, L. 1998: Studies on synthesis and bioactivity of 2-alkenyl-4(1H)-quinolone Yao Xue Xue Bao 33(4): 269-274
Hooper, D.C.; Wolfson, J.S. 1989: Bacterial resistance to the quinolone antimicrobial agents American Journal of Medicine 87(6c): 17S-23S
Evstigneev, M.P.; Baranovskiĭ, S.F.; Rybakova, K.A.; Davis, D.B. 2006: 1H NMR study of the complexation of the quinolone antibiotic norfloxacin with DNA Molekuliarnaia Biologiia 40(5): 894-899
Lim, V.K. 1989: In vitro activity of some newer quinolone compounds Singapore Medical Journal 30(1): 63-65
De Mey, C.; Scharpe, S.; De Bock, R.; Bossaert, L. 1981: Predictive pharmacokinetics of amikacin using actually measured and assumed parameters, applied in 1-compartment linear pharmacokinetics Archives Internationales de Pharmacodynamie et de Therapie 253(2): 323-324
Daniel, W.; Syrek, M.; Janczar, L.; Boksa, J. 1995: The pharmacokinetics of promazine and its metabolites after acute and chronic administration to rats--a comparison with the pharmacokinetics of imipramine Polish Journal of Pharmacology 47(2): 127-136
Murata, M.; Tamai, I.; Sai, Y.; Nagata, O.; Kato, H.; Sugiyama, Y.; Tsuji, A. 1998: Hepatobiliary transport kinetics of HSR-903, a new quinolone antibacterial agent Drug Metabolism and Disposition: the Biological Fate of Chemicals 26(11): 1113-1119
Van der Willigen, A.H.; Degener, J.E.; Vogel, M.; Stolz, E.; Wagenvoort, J.H. 1990: In vitro activities of seven quinolone derivatives against Neisseria gonorrhoeae Arzneimittel-Forschung 40(6): 684-685
Van Linthoudt, D.; D'Oro, A.; Ott, H. 1994: What is your diagnosis? Bilateral Achilles tendinitis associated with quinolone treatment Schweizerische Rundschau für Medizin Praxis 83(8): 201-202
Rodrigues, C.; Mehta, A.; Joshi, V.R. 1998: Quinolone resistant enteric fever--problems and remedies Journal of the Association of Physicians of India 46(8): 751-752
Grosset, J. 1990: Norfloxacin: a broad-spectrum quinolone for superficial eye infections Pathologie-Biologie 38(7): 735-741
Morimoto, K.; Kinoshita, H.; Nakatani, S.; Sakai, K.; Fujimoto, M.; Ohno, K.; Ueda, T.; Ohmori, K.; Yamazaki, O.; Doi, S. 1992: Efficacy of a new quinolone, levofloxacin in patients with surgical infections Japanese Journal of Antibiotics 45(3): 258-264